KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Inventory Average (2018 - 2025)

Historic Inventory Average for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to $7.8 million.

  • Bionano Genomics' Inventory Average fell 5360.08% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 5360.08%. This contributed to the annual value of $17.0 million for FY2024, which is 3540.16% down from last year.
  • Bionano Genomics' Inventory Average amounted to $7.8 million in Q3 2025, which was down 5360.08% from $9.1 million recorded in Q2 2025.
  • Bionano Genomics' 5-year Inventory Average high stood at $32.8 million for Q2 2023, and its period low was $3.2 million during Q1 2021.
  • Its 5-year average for Inventory Average is $17.0 million, with a median of $16.9 million in 2024.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 36503.91% in 2022, then plummeted by 5360.08% in 2025.
  • Bionano Genomics' Inventory Average (Quarter) stood at $10.7 million in 2021, then soared by 156.02% to $27.4 million in 2022, then fell by 10.01% to $24.7 million in 2023, then plummeted by 48.41% to $12.7 million in 2024, then plummeted by 38.37% to $7.8 million in 2025.
  • Its Inventory Average stands at $7.8 million for Q3 2025, versus $9.1 million for Q2 2025 and $10.3 million for Q1 2025.